Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantation
- 27 May 2015
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 62 (9) , 1650-1655
Abstract
Background It is unclear whether there is a causative relationship between the development of metabolic syndrome (MS) and increased risk of early cardiovascular morbidity in patients receiving hematopoietic stem cell transplantation (HSCT) during childhood. Early identification of risk factors associated with insulin resistance, MS, and abnormal glucose tolerance during childhood or adolescence in these patients could represent a useful tool for preventing cardiovascular disorders. Procedure In a single‐center, prospective, descriptive, cross‐sectional study, we studied 45 survivors of hematological malignancies (age: 13.9 ± 4.8 years) treated with HSCT before the age of 18 years and 90 matched healthy controls. We collected clinical, imaging, and laboratory data including oral glucose tolerance test (OGTT). Results 7/45 patients (15.6%) showed abnormal glucose tolerance at OGTT, 1/45 (2.2%) was obese, and none fulfilled the criteria for MS. A waist/height ratio >0.5 was associated with patients with abnormal glucose tolerance (85.7% of cases), compared to patients with normal glucose tolerance (42.1%) and controls (23.3%). In patients with abnormal glucose tolerance, use of total body irradiation (TBI) as conditioning regimen was more common, and time elapsed from HSCT was longer. Conclusions Patients treated with HSCT may develop insulin resistance early after transplantation. They do not show overt obesity, but have redistribution of fat tissue with central fat accumulation. The main factors associated with increased metabolic risk are TBI and time from HSCT. Evaluation of MS and glucose tolerance should be part of hormonal follow‐up, which should be routinely proposed to these patients. Pediatr Blood Cancer 2015;62:1650–1655.Keywords
This publication has 46 references indexed in Scilit:
- Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular diseaseBlood, 2012
- Longitudinal Changes in Body Mass and Composition in Survivors of Childhood Hematologic Malignancies After Allogeneic Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2012
- Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort studyThe Lancet Oncology, 2012
- NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges—Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive RisksTransplantation and Cellular Therapy, 2011
- Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor StudyLeukemia, 2010
- Diabetes Mellitus in Long-term Survivors of Childhood CancerArchives of internal medicine (1960), 2009
- Waist-to-Height Ratio, a Useful Index to Identify High Metabolic Risk in Overweight ChildrenThe Journal of Pediatrics, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescentsThe Journal of Pediatrics, 2004
- Analysis of serial measurements in medical research.BMJ, 1990